Versant Capital Management’s Usana Health Sciences USNA Stock Holding History

Versant Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9K	Buy	1,588 +1,487	+1,472%	+$28K	﹤0.01%	1636
2026 Q1	$1.76K	Sell	101 -1,160	-92%	-$23K	﹤0.01%	2583
2025 Q4	$24.8K	Buy	1,261 +1,048	+492%	+$21.7K	﹤0.01%	1505
2025 Q3	$5.87K	Buy	213 +74	+53%	+$2.28K	﹤0.01%	2146
2025 Q2	$4.24K	Sell	139 -1,011	-88%	-$28.7K	﹤0.01%	2212
2025 Q1	$31K	Buy	1,150 +971	+542%	+$30.7K	0.01%	1093
2024 Q4	$6.42K	Buy	179 +158	+752%	+$5.91K	﹤0.01%	1639
2024 Q3	$796	Hold	21	–	–	﹤0.01%	1792
2024 Q2	$950	Hold	21	–	–	﹤0.01%	1684
2024 Q1	$1.02K	Hold	21	–	–	﹤0.01%	1536
2023 Q4	$1.13K	Hold	21	–	–	﹤0.01%	1476
2023 Q3	$1.23K	Hold	21	–	–	﹤0.01%	1469
2023 Q2	$1.32K	Hold	21	–	–	﹤0.01%	1520
2023 Q1	$1.32K	Hold	21	–	–	﹤0.01%	1377
2022 Q4	$1.12K	Sell	21 -257	-92%	-$13.9K	﹤0.01%	1273
2022 Q3	$16K	Buy	278 +105	+61%	+$6.94K	0.01%	498
2022 Q2	$13K	Hold	173	–	–	﹤0.01%	585
2022 Q1	$14K	Sell	173 -20	-10%	-$1.8K	﹤0.01%	591
2021 Q4	$20K	Sell	193 -2	-1%	-$200	0.01%	506
2021 Q3	$18K	Hold	195	–	–	0.01%	516
2021 Q2	$20K	Sell	195 -130	-40%	-$13.1K	0.01%	493
2021 Q1	$32K	Hold	325	–	–	0.01%	412
2020 Q4	$25K	Hold	325	–	–	0.01%	451
2020 Q3	$23K	Hold	325	–	–	0.01%	391
2020 Q2	$23K	Sell	325 -23	-7%	-$1.8K	0.01%	380
2020 Q1	$20K	Buy	348 +289	+490%	+$20.1K	0.01%	371
2019 Q4	$4K	Hold	59	–	–	﹤0.01%	1028
2019 Q3	$4K	Buy	59 +45	+321%	+$3.02K	﹤0.01%	1047
2019 Q2	$1K	Hold	14	–	–	﹤0.01%	1332
2019 Q1	$1K	Hold	14	–	–	﹤0.01%	1492
2018 Q4	$1K	Hold	14	–	–	﹤0.01%	1404
2018 Q3	$1K	Hold	14	–	–	﹤0.01%	1450
2018 Q2	$1K	Hold	14	–	–	﹤0.01%	1432
2018 Q1	$1K	Hold	14	–	–	﹤0.01%	1415
2017 Q4	$1K	Hold	14	–	–	﹤0.01%	1465
2017 Q3	$0	Hold	14	–	–	﹤0.01%	1579
2017 Q2	$0	Hold	14	–	–	﹤0.01%	1549
2017 Q1	$0	Hold	14	–	–	﹤0.01%	1543
2016 Q4	$0	Hold	14	–	–	﹤0.01%	1536
2016 Q3	$0	Buy	+14	New	+$924	﹤0.01%	1496

Other funds holding USNA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Unison Advisors Washington, District of Columbia $1.43B AUM 23.44% 1-Year Est. Return

PCM

Park Capital Management Madison, Wisconsin $170M AUM 83.62% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CAL

Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Versant Capital Management's USNA Position: Q2 2026 in Review

Versant Capital Management increased its Usana Health Sciences (USNA) stake by 1,472% in Q2 2026, buying an estimated $28K and bringing the position to 1,588 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Versant Capital Management first reported a position in USNA in Q3 2016 and has held it in 40 quarters since. 12 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Versant Capital Management held 1,588 shares of Usana Health Sciences worth $33.9K as of Q2 2026.
Versant Capital Management bought 1,487 Usana Health Sciences shares in Q2 2026, an estimated $28K.
Usana Health Sciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1636 holding.
Versant Capital Management first reported a position in Usana Health Sciences in Q3 2016 and has held it in 40 quarters since.
12 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.